心血管内科患者临床用药常见问题及其合理用药分析  

Analysis of common problems in clinical medication and rational drug usein patients with cardiovascular

作　　者：侯光强[1] 

机构地区：[1]四川省广元市第四人民医院,628001

出　　处：《检验医学与临床》2017年第A02期124-125,共2页Laboratory Medicine and Clinic

摘　　要：目的 为了了解心血管内科合理用药情况,推动药物合理使用的发展.方法 本研究纳入的用药信息均来至本院心血管内科,时间在2014年12月到2016年12月,总计纳入心血管相关疾病患者2200例.本研究以《中国药典》和《相关疾病的治疗指南》为评价用药合理性的标准,判断用药的合理性.结果 967例患者出现用药的不合理,不合理类型发生率从高到低分别为：缺乏临床循证证据发生率20.59%,无主次盲目给药发生率为11%,配伍不合理发生率为5.59%,用药缺乏针对性发生率为4.22%,服用方式不合理1.45%,服用方式不合理1.09%.结论 心血管内科存在一定的用药不合理性,有过有效的措施来避免不合理性,是保证患者疗效和安全的后盾.Objective To understand the cardiovascular internal medicine rational drug use situation,and promote the develop-ment of rationaldrug use.Methods This study included medication information have come to our hospital cardiovascular internal medicine,time in December 2014 to December 2016,the total in 2200 patients with cardiovascular related diseases.This research to＂Chinese pharmacopoeia＂and related disease treatment guidelines to evaluate the rationality of medical standards,to judge the ra-tionality of drug use.Results 967 cases of patients with medication is not reasonable,unreasonable type rate from high to low are：lack of 20.59% incidence of clinical evidence-based evidence,no blind dosing rate is 11%,primary and secondary 5.59% incidence of compatibility is not reasonable,lack target rate of 4.22%,taking way unreasonable 1.45%,1.09% take way is not reasonable. Conclusion Cardiovascular internal medicine drug has certain irrationality,have effective measures to avoid the unreasonable,is to ensure that patients with curative effect and safety of backing.

关 键 词：心血管内科 用药常见问题 用药合理性 

分 类 号：R54[医药卫生—心血管疾病]